XSHE
000638
Market cap41mUSD
Apr 15, Last price
0.89CNY
Name
Vanfund Urban Investment and Development Co Ltd
Chart & performance
P/E
—
P/S
1.12
EPS
—
Div yield, %
—
Shrs. gr., 5y
-0.19%
Rev. gr., 5y
-5.22%
Revenues
247m
-37.01%
Net income
-51m
L
CFO
0
-100.00%
Dividend
Nov 11, 20080.549 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Beijing, China, Vanfund Urban Investment and Development Co., Ltd. operates across a diverse range of sectors. The company specializes in creating medical information software specifically for the Chinese market. Beyond its technology ventures, Vanfund also engages in the processing and trading of grain, alongside offering comprehensive medical and health informatization services. Its portfolio further extends to land consolidation and development projects, as well as mining operations. This enterprise was formerly identified as Vanfund Real Estate Co., Ltd., but adopted its current corporate identity in April 2013.
Key people
Zibin Guo
Vice Chairman of the Board, Deputy General Manager, Secretary of the Board · since 2025
Zhiwang Zhan
Chief Financial Officer · since 2022
Weiya Dong
Deputy General Manager · since 2022
Qu Cao
Director · since 2025
Yu Liu
Chairman of the Board, General Manager · since 2025
Gelin Liu
Director · since 2019
Jianqing Su
Director · since 2016
Hanhui Zhang
Director · since 2024
Qingchun Meng
Independent Director · since 2025
Lili Sun
Independent Director · since 2021
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||